Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
Authors
Keywords
Breast cancer, Invasive lobular carcinoma, Non-lobular carcinoma, Pathological complete response, Neoadjuvant chemotherapy, Survival
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 144, Issue 1, Pages 153-162
Publisher
Springer Nature
Online
2014-02-07
DOI
10.1007/s10549-014-2861-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
- (2013) Y Delpech et al. BRITISH JOURNAL OF CANCER
- Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC)
- (2013) N. Biglia et al. EJSO
- Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial
- (2013) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic grade adds prognostic value in invasive lobular carcinoma†
- (2012) O. Metzger-Filho et al. ANNALS OF ONCOLOGY
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
- (2012) Michael Untch et al. LANCET ONCOLOGY
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of special types of luminal breast cancer
- (2011) M. Colleoni et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics
- (2011) E. H. Lips et al. BREAST CANCER RESEARCH AND TREATMENT
- Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
- (2011) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)
- (2010) A. Noske et al. BREAST CANCER RESEARCH AND TREATMENT
- Neoadjuvant Chemotherapy: Not the Best Option in Estrogen Receptor–Positive, HER2-Negative, Invasive Classical Lobular Carcinoma of the Breast?
- (2010) Arnie Purushotham et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study
- (2010) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Lobular breast carcinoma and its variants
- (2010) Emad A. Rakha et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation
- (2009) Judy C. Boughey et al. ANNALS OF SURGICAL ONCOLOGY
- Clinicopathologic characteristics of invasive lobular carcinoma of the breast
- (2008) Enrico Orvieto et al. CANCER
- The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer
- (2008) Lindy A. Diepenmaat et al. RADIOTHERAPY AND ONCOLOGY
- Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes
- (2007) Emad A. Rakha et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started